Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITEDDate of Board Meeting
Dawnrays Pharmaceutical Holdings Ltd. on 6ix
Earlier from Dawnrays Pharmaceutical
- Voluntary Announcement New Product Pharmaceutical Registration Approval
- Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared
Later from Dawnrays Pharmaceutical
- Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2011, Net Profit after Tax Dropped 12.3% to RMB 146.31 Million, A Final Dividend of HK$ 0.068 per Share was Declared
- List of Directors and their Role and Function
- Change in board lot size
- Announcement of Interim Results for the six months ended 30 June 2017
- Discloseable transaction-construction agreements
Follow Dawnrays Pharmaceutical into a list and get an email when it puts out news.
Follow Dawnrays Pharmaceutical